FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Ascend Laboratories Aripiprazole Tablets Recall

Aripiprazole Tablets, USP, 10 mg, 30-count bottles, Rx only, Manufactured by: Alken Lab…

Ascend Laboratories, LLC · Bedminster, NJ

Risk level
Class II
Reported by FDA
Sep 24, 2025
Recall ID
D-0645-2025
Check your lot numberHow we source this data

Summary

Ascend Laboratories recalled Aripiprazole Tablets starting Aug 28, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0645-2025 on Sep 24, 2025. Reason: Superpotent drug. Status: Ongoing.

Why it was recalled

Superpotent drug

Product description

Aripiprazole Tablets, USP, 10 mg, 30-count bottles, Rx only, Manufactured by: Alken Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054. NDC: 67877-432-03

Lot numbers, UPCs & expiration codes

Lot #: 24144162, Exp. Date 09/2027

Where it was sold

Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0645-2025
Classification
Class II
Status
Ongoing
Recall initiated
Aug 28, 2025
FDA report date
Sep 24, 2025
Quantity
2,256 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Ascend Laboratories, LLC

Original FDA data

Every field from FDA enforcement report D-0645-2025, exactly as published.

Show all FDA fields
City
Bedminster
State
NJ
Status
Ongoing
Country
United States
Event ID
97511
Address
135 Us Highway 202 206 Ste 15
Code information
Lot #: 24144162, Exp. Date 09/2027
Postal code
07921-2608
Report date
Sep 24, 2025
Product type
Drugs
Recall number
D-0645-2025
Classification
Class II
Recalling firm
Ascend Laboratories, LLC
Product quantity
2,256 bottles
Reason for recall
Superpotent drug
Voluntary / mandated
Voluntary: Firm initiated
Product description
Aripiprazole Tablets, USP, 10 mg, 30-count bottles, Rx only, Manufactured by: Alken Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054. NDC: 67877-432-03
Distribution pattern
Nationwide in the USA.
Recall initiation date
Aug 28, 2025
Initial firm notification
Letter
Center classification date
Sep 12, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0645-2025, published Sep 24, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls